Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Basit Salik"'
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-19 (2020)
Abstract Immune checkpoint blockade (ICB) therapies such as anti-programmed death 1 (PD-1) and anti-CTLA-4 (cytotoxic T lymphocyte-associated protein 4) have dramatically transformed treatment in solid tumor oncology. While immunotherapeutic approach
Externí odkaz:
https://doaj.org/article/3516c5caeda84522b90911171fbcb438
Autor:
Edwige Roy, Ho Yi Wong, Rehan Villani, Thomas Rouille, Basit Salik, Seen Ling Sim, Valentine Murigneux, Mitchell S. Stark, J. Lynn Fink, H. Peter Soyer, Graeme Walker, J. Guy Lyons, Nicholas Saunders, Kiarash Khosrotehrani
Publikováno v:
Cell Reports, Vol 31, Iss 9, Pp - (2020)
Summary: To better understand the influence of ultraviolet (UV) irradiation on the initial steps of skin carcinogenesis, we examine patches of labeled keratinocytes as a proxy for clones in the interfollicular epidermis (IFE) and measure their size v
Externí odkaz:
https://doaj.org/article/4f40b994e84b446fa257776011c077e1
Autor:
Estrella Gonzales-Aloy, Patrick Connerty, Basit Salik, Bing Liu, Andrew J. Woo, Michelle Haber, Murray D. Norris, Jianlong Wang, Jenny Y. Wang
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
Externí odkaz:
https://doaj.org/article/436963bc0781433d9f72fe5803c06bc1
Autor:
Mika Casey, Kane Segawa, Soi Cheng Law, Muhamamed Bilal Sabdia, Bianca Nowlan, Basit Salik, Carol Lee, Clay Winterford, Sally Pearson, Jason Madore, William C. Dougall, Maher K. Gandhi, Kyohei Nakamura
Publikováno v:
Leukemia.
Redirection of tumor-associated macrophages to eliminate tumor cells holds great promise for overcoming therapeutic resistance to rituximab and other antibody drugs. Here, we determined the expression of ectonucleotidases CD39 and CD73 in diffuse lar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17accbe8719ced30bc208c800051b72d
https://pubmed.ncbi.nlm.nih.gov/36539557
https://pubmed.ncbi.nlm.nih.gov/36539557
Autor:
Chang Su, Lochlan J Fennell, Catherine E Bond, Alexandra M Kane, Genevieve Kerr, Thierry Jardé, Diana Micati, Rebekah M Engel, Wing Hei Chan, Sara Hlavca, Stuart Archer, Paul J McMurrick, Heinz Hammerlindl, Fayth Lim, Basit Salik, Diane M McKeone, Gunter Hartel, Jennifer Borowsky, Rahul Ladwa, Barbara A Leggett, Helmut Schaider, Helen E Abud, Glen M Boyle, Matthew E Burge, Vicki LJ Whitehall
PurposeRegorafenib is a multi-kinase inhibitor approved for refractory metastatic colorectal cancer. Previous studies have suggested that combining kinase inhibitors with aspirin may improve patient outcomes. We aimed to determine the effects of aspi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a08e038486c64e20f79f3d5071b95732
https://doi.org/10.1101/2022.02.11.480021
https://doi.org/10.1101/2022.02.11.480021
Autor:
Basit Salik, Andrew J. Woo, Estrella Gonzales-Aloy, Bing Liu, Murray D. Norris, Patrick Connerty, Michelle Haber, Jianlong Wang, Jenny Y. Wang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::891d8ee372a93816f56dd076d4412fe0
https://europepmc.org/articles/PMC6601101/
https://europepmc.org/articles/PMC6601101/
Autor:
Jianlong Wang, Karsten Spiekermann, Andrew J. Woo, Basit Salik, Philip J. Hogg, Jennifer R Lynch, Binje Vick, Murray D. Norris, Aster E. Pijning, Toby Trahair, Halina H.L. Leung, Jenny Y. Wang, Irmela Jeremias, Tao Liu, Michelle Haber, Patrick Connerty
Publikováno v:
Leukemia 33, 1400-1410 (2019)
Leukemia
Leukemia
Abnormal metabolism is a fundamental hallmark of cancer and represents a therapeutic opportunity, yet its regulation by oncogenes remains poorly understood. Here, we uncover that JMJD1C, a jumonji C (JmjC)-containing H3K9 demethylase, is a critical r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f896e7480c63b074271cc49db9f0f5b5
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=55123
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=55123
Publikováno v:
Blood. 134:2669-2669
Acute myeloid leukemia (AML) is associated with high relapse rates and poor survival, with limited response to conventional cancer therapy and lacking effective targeting of highly self-renewing leukemic stem cells (LSCs). The mechanism underlying th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::389f1bd5fb71411d84b78333c6220779
https://doi.org/10.1182/blood-2019-129704
https://doi.org/10.1182/blood-2019-129704